Clinical Research Associate interview questions and how to answer them

A CRA interview is mostly a test of judgment under Good Clinical Practice. Expect scenario questions about things going wrong at a site, because that's the part of the job the interviewers can't teach you in a training module. Bring real examples from trials you've touched, even from the coordinator side.

11 questions7 minute read

Part 1

1.Walk me through what you do on a routine monitoring visit.

Why they ask

It's the core of the job, and the order of your answer shows whether you've done one or just watched.

How to answer

  • Prep before the visit: review the last report's open items, EDC queries and the enrollment status in the CTMS
  • Confirm the agenda and the investigator's time with the coordinator ahead of arrival
  • On site: check consent forms first, then source data verification against the CRFs, drug accountability and the investigator site file
  • Meet the investigator to go over findings before leaving
  • Write the visit report and send the follow-up letter within the sponsor's timeline

2.You find a patient was enrolled before signing the current version of the consent form. What do you do?

Why they ask

Consent problems are the finding that can sink a site, and they want to see you escalate without panicking.

How to answer

  • Confirm the facts: which version was signed, when the new one was approved by the IRB, what procedures happened in between
  • Document it as a protocol deviation and notify the study lead per the monitoring plan
  • Make sure the patient is reconsented on the correct version as soon as possible
  • Check whether other patients at the site have the same problem
  • Work with the coordinator on a fix, like a version tracking log, so it doesn't repeat

3.How do you decide what to source-verify when the monitoring plan is risk-based?

Why they ask

Many sponsors have moved away from checking every data point, and they need CRAs who can focus on what matters.

How to answer

  • Start from the monitoring plan's list of critical data and processes, such as eligibility, primary endpoints and safety data
  • Use central monitoring signals and key risk indicators to target sites and patients
  • Always verify consent and serious adverse events regardless of sampling
  • Widen the review when a sample turns up repeated errors
4.During source review you notice a hospitalization in the clinic notes that was never reported as a serious adverse event. Walk me through your next steps.

Why they ask

Safety reporting has strict clocks and legal weight, and a missed SAE is the kind of finding regulators notice.

How to answer

  • Raise it with the coordinator and investigator right away, not in the report next week
  • Make sure the site submits the SAE report to the sponsor safety team immediately, since the reporting clock starts from site awareness
  • Escalate to the study lead and document the late report as a deviation
  • Look at whether the site's process for catching hospitalizations is broken and retrain if so
5.A principal investigator keeps skipping your end-of-visit meetings. How do you handle it?

Why they ask

Investigators are busy doctors, and CRAs need to hold them accountable without burning the relationship.

How to answer

  • Book the time ahead of the visit through the coordinator and keep it short
  • Bring a tight summary of findings that actually need the PI, not everything
  • Remind them, politely, that investigator oversight is their responsibility under GCP
  • If it keeps happening, document it and escalate to your manager or the sponsor

Part 2

6.What goes into a site initiation visit, and what are you trying to prevent?

Why they ask

A clean start-up saves months of findings later, and it shows you understand the whole study lifecycle.

How to answer

  • Train the site team on the protocol, eligibility criteria and study procedures
  • Walk through EDC access, lab kits, drug storage and temperature logs
  • Confirm the delegation log and training records are complete before any patient is screened
  • Set expectations for data entry timelines and SAE reporting
7.How do you manage several sites when deadlines collide?

Why they ask

Juggling travel, reports and follow-ups is where junior CRAs fall behind.

How to answer

  • Keep a running tracker of visit dates, report due dates and open action items for every site
  • Write reports on the plane or the same evening while the visit is fresh
  • Prioritize by risk: safety and consent issues before cosmetic queries
  • Flag early to your manager when a visit window can't be met
8.Tell me about drug accountability. What would make you worry at a site?

Why they ask

Investigational product errors can affect patient safety and the validity of the trial data.

How to answer

  • Reconcile dispensed, returned and remaining product against the dosing logs and patient records
  • Check temperature logs and what the site did about any excursions
  • Watch for missing returns, unexplained counts or product used past expiry
  • Confirm blinding is protected if the study is blinded
9.What's a protocol deviation you caught and how did it get resolved?

Why they ask

They want proof you've found real problems, not just described them.

How to answer

  • Pick a real example, from monitoring or from the coordinator side
  • Say how it was found and why it mattered to the data or the patient
  • Explain the corrective and preventive action and whether it stuck
10.How do you write up a finding so the site actually fixes it?

Why they ask

Vague visit reports and follow-up letters create repeat findings and annoyed sites.

How to answer

  • State exactly what was found, where, and for which patient ID
  • Tie it to the protocol section or GCP requirement
  • Assign an owner and a due date
  • Follow up at the next visit and close it only when you've seen the fix

Part 3

11.Why do you want to move into monitoring?

Why they ask

The travel and pressure push people out, and they want to know you've thought about it.

How to answer

  • Give a reason tied to the work, like liking the investigative side of source review
  • Show you know what the travel is like and have a plan for it
  • Connect your current experience to what makes a good CRA

Questions to ask them

Ask at least two. It shows you're picking them too.

  • How many sites would I carry at the start, and how does that change once I'm fully trained?
  • What does co-monitoring look like before I run visits on my own?
  • How much of the monitoring here is on-site versus remote?
  • Which therapeutic areas and study phases would I most likely be assigned?
  • What's the expected turnaround on visit reports, and who reviews them?